The study aims to investigate the effectiveness of Eylea in patients with wet age-related macular degeneration in routine clinical practice in Germany. The study is purely observational, only data from routine treatment are to be collected. The treatment and treatment conditions are solely at discretion of the treating physician.
Study Type
OBSERVATIONAL
Enrollment
988
Patients will be followed-up for 24 months
Unnamed facility
Multiple Locations, Germany
Mean change of visual acuity for the total patient population
Time frame: Baseline, 12 and 24 months
Mean change of visual acuity for the subgroup of pretreated patients
Time frame: Baseline, 12 and 24 months
Mean change of visual acuity for the subgroup of non-pretreated patients
Time frame: Baseline, 12 and 24 months
Monitoring of disease activity
Monitoring of disease activity in routine clinical practice setting will be assessed e.g. by determining the o No. of clinical visits (visits for injections) o No. of monitoring visits (visits only for diagnostic purposes, but without injections) o No. of safety visits after the injection (visits only for safety checks after injection) o No. of visits outside the study center o No. of OCT (optical coherence tomography) assessments per patient after 12 and 24 months
Time frame: after 12 and 24 months
Monitoring of treatment patterns
same assessment as indicated for "Monitoring of disease activity"
Time frame: after 12 and 24 months
Mean time from indication of Eylea-treatment by the treating physician to start of treatment
Time frame: after 12 and 24 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.